Kruger Products to Build New TAD Tissue Plant in the U.S.
Kruger Products has unveiled plans to build a new state-of-the-art tissue facility in the western United States, a major investment designed to support the company’s fast-growing U.S. consumer tissue business.
The announcement accompanied the company’s third-quarter financial release.
The project includes a modern through-air-dry (TAD) machine and associated converting lines, with an estimated annual capacity of 75,000 metric tonnes. Production is expected to begin in 2028.
Kruger Products has invested more than $1 billion in Canadian manufacturing since 2018, and the new U.S. site marks the next phase of its North American expansion strategy. The facility will enhance service to U.S. retailers and strengthen the company’s position in the premium and ultra-premium tissue categories.